A study published Tuesday in AJP in Advance suggests patients with bipolar II depression who take se...

An article published in the February issue of the American Journal of Psychiatry shows that pramipex...

An eight-week, randomized, controlled study published today in AJP in Advance has found that a 1.5 m...

The American Heart Association (AHA) has issued a scientific statement recommending that major depre...

In July, lurasidone—a dopamine receptor 2 (D2) blocker originally approved to treat schizophrenia—wa...

The U.S. Food and Drug Administration (FDA) has approved new indications for the atypical antipsycho...